Bixiye
QP66-20 Updates to Injectable Drug Authorization Requests
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2151 - 2160 ee natiijooyinka 3563
Bixiye
QP64-20 Medical Drug Update for New to Market Viltolarsen
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP68-20 MHCP Pharmacy Benefit Update - Eylea®, Iluvien®, Lucentis®, Ozurdex® ,Retisert™ and Yutiq®
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP62-20 Medicaid Sleep Management – Home Sleep Studies
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP63-20 MDH Guidance to Support Hospital Patients with Disabilities and Pediatric Patients
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP67-20 Commercial Pharmacy Benefit Exclusion for DurystaTM, Iluvien®, Retisert® and Yutiq®
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP69-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Risdiplam
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP65-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Satralizumab
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
P48-20 CMS Issued Prior Authorization Requirements for Certain Hospital Outpatient Department (OPD) Services – Effective July 1, 2020
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Bixiye
2020 July Bulletins
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020